Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.9
7.8
Journals
Vaccines
Special Issues
COVID-19 Vaccination Strategies and Perspectives in the United States
share announcement

COVID-19 Vaccination Strategies and Perspectives in the United States

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".

Deadline for manuscript submissions: closed (15 December 2022) | Viewed by 4504

Special Issue Editors

Dr. Leslie Elliott

E-Mail Website
Guest Editor
School of Public Health, University of Nevada, Reno, NV 89557, USA
Interests: epidemiology; public health issues; environmental and occupational health; children’s health
Dr. Dana Loomis

E-Mail Website
Guest Editor
Plumas County Public Health Agency, Quincy, CA 95971, USA
Interests: epidemiology; public health

Special Issue Information

Dear Colleagues,

In the United States, the response to the COVID-19 pandemic has been marked by political and social conflict, with inconsistent health messages from the government, health agencies and the media. In addition to doubts about the reality of the pandemic, large segments of the US population have been skeptical about the safety and effectiveness of vaccines against the novel SARS-CoV2 virus, especially those using mRNA technology. The skepticism resulted in widespread distribution challenges once the vaccines received emergency-use authorization from the US Food and Drug Administration, such that the vaccination rate slowed dramatically in the second half of 2021.

As of December 2021, approximately 62% of the US population has been fully vaccinated. However, regional, state, and county vaccination rates are extremely variable, with some states reporting counties with fewer than 20% and greater than 98% of the population vaccinated. Notable differences in vaccination coverage by age, race, and ethnicity have also been reported. Elected officials and public health agencies have used various strategies to encourage residents to become vaccinated, but vaccine hesitancy remains high in some areas. This issue of Vaccines focuses on the COVID-19 vaccine experience throughout the United States, with emphasis on vaccine hesitancy and acceptance, strategies to enhance vaccination coverage and promote equity, and the health and social consequences of low vaccination rates. We invite you to share your research, review, or opinion papers in any of these areas, with the hope of bringing more understanding to this ongoing issue and to aid in future vaccine efforts.  

Dr. Leslie Elliott
Dr. Dana Loomis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Dr. Leslie Elliott
Dr. Dana Loomis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID
  • policy
  • public health
  • vaccine
  • equity
  • pandemic
  • coronavirus

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

13 pages, 1008 KiB  
Article
Ensuring Equitable COVID-19 Vaccine Allocation in New Hampshire: The First Eight Months toward a New Era
by Taylor D. Selembo, Elizabeth A. Talbot, Christophe T. Courtine, Elizabeth R. Daly, Torane W. Hull and Kirsten J. Durzy
Vaccines 2022, 10(9), 1421; https://doi.org/10.3390/vaccines10091421 - 29 Aug 2022
Cited by 1 | Viewed by 1846
Abstract
The global coronavirus disease 2019 (COVID-19) pandemic has been exacerbated by social vulnerabilities and racial disparities, resulting in disproportionate morbidity and mortality that require continued attention to strategies that ensure equitable vaccine allocation. The State of New Hampshire (NH) developed a transparent framework [...] Read more.
The global coronavirus disease 2019 (COVID-19) pandemic has been exacerbated by social vulnerabilities and racial disparities, resulting in disproportionate morbidity and mortality that require continued attention to strategies that ensure equitable vaccine allocation. The State of New Hampshire (NH) developed a transparent framework to guide COVID-19 vaccine allocation plans, of which one key component was the allocation of 10% of vaccine supply to disproportionately impacted and highly vulnerable populations, predominantly identified through a national vulnerability index. The process, operational approaches, ethical challenges, and unanticipated consequences resulted in many valuable lessons learned. Equitable allocation of this limited and critical pandemic countermeasure required public understanding and engagement, which was achieved through a publicly available framework that was flexible, resourced using public funds, and widely communicated. Broad partnerships were also critical to addressing disparities in the delivery of vaccine. The lessons learned and described here will facilitate more nimble and equitable jurisdictional responses in future public health emergencies. Full article
(This article belongs to the Special Issue COVID-19 Vaccination Strategies and Perspectives in the United States)
►▼ Show Figures

Figure 1

10 pages, 244 KiB  
Article
Vaccine Acceptance and Hesitancy among College Students in Nevada: A State-Wide Cross-Sectional Study
by Leslie Elliott and Kanyeemengtiang Yang
Vaccines 2022, 10(1), 105; https://doi.org/10.3390/vaccines10010105 - 11 Jan 2022
Cited by 18 | Viewed by 2171
Abstract
The purpose of this study was to identify factors related to COVID-19 vaccine acceptance and hesitancy in a diverse state-wide population of students. An electronic survey was emailed to students in the Nevada System of Higher Education to assess effects of the pandemic. [...] Read more.
The purpose of this study was to identify factors related to COVID-19 vaccine acceptance and hesitancy in a diverse state-wide population of students. An electronic survey was emailed to students in the Nevada System of Higher Education to assess effects of the pandemic. The survey included questions related to vaccine status, interest in receiving the COVID-19 vaccine, factors influencing these decisions, and sources of health information. Among the 3773 respondents, over half (54%) were accepting of the vaccine, including vaccinated students (18.9%). Nearly one quarter (23.5%) expressed hesitancy to receive the vaccine, citing concerns about side effects and the need for more research. Factors related to hesitancy included female gender, increasing age, place of residence, marital status, and Black or Native American race. Vaccine hesitant respondents were less likely than other respondents to rely on public health agencies or newspapers for health information, and more likely to rely on employers, clinics, or “no one”. Culturally appropriate efforts involving COVID-19 vaccine information and distribution should target certain groups, focusing on factors such as side effects, development and testing of the vaccine. Research should investigate sources of health information of people who are hesitant to receive vaccines. Full article
(This article belongs to the Special Issue COVID-19 Vaccination Strategies and Perspectives in the United States)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop